Travel in the Time of COVID: A Review of International Travel Health in a Global Pandemic
- PMID: 35965881
- PMCID: PMC9361911
- DOI: 10.1007/s11908-022-00784-3
Travel in the Time of COVID: A Review of International Travel Health in a Global Pandemic
Abstract
Purpose of review: This review critically considers the impact of the COVID-19 pandemic on global travel and the practice of travel medicine, highlights key innovations that have facilitated the resumption of travel, and anticipates how travel medicine providers should prepare for the future of international travel.
Recent findings: Since asymptomatic transmission of the virus was first recognized in March 2020, extensive efforts have been made to characterize the pattern and dynamics of SARS-CoV-2 transmission aboard commercial aircraft, cruise ships, rail and bus transport, and in mass gatherings and quarantine facilities. Despite the negative impact of further waves of COVID-19 driven by the more transmissible Omicron variant, rapid increases of international tourist arrivals are occurring and modeling anticipates further growth. Mitigation of spread requires an integrated approach that combines masking, physical distancing, improving ventilation, testing, and quarantine. Vaccines and therapeutics have played a significant role in reopening society and accelerating the resumption of travel and further therapeutic innovation is likely.
Summary: COVID-19 is likely to persist as an endemic infection, and surveillance will assume an even more important role. The pandemic has provided an impetus to advance technology for telemedicine, to adopt mobile devices and GPS in contact tracing, and to apply digital applications in research. The future of travel medicine should continue to harness these novel platforms in the clinical, research, and educational arenas.
Keywords: Health passport; Quarantine; SARS-CoV-2; Sustainable travel; Testing; Transmission; Transport; Travel medicine; Vaccine.
© The Author(s) 2022.
Conflict of interest statement
Conflict of InterestDr. Flaherty has received conference registration support as an Executive Board member of the Travel Medicine Society of Ireland (former) and International Society of Travel Medicine (current). Dr. Chen reports honoraria from Shoreland Inc, Valneva, Takeda, Sanofi-Pasteur, Emergent BioSolutions, and Merck. Dr. Hamer reports consulting fees and honoraria from Xenophon Strategies, Inc., Trinity Biotech, LLC, Equinox, Major League Soccer, PGA of America, Valneva, and Takeda.
Similar articles
-
Coronavirus Disease 2019 (COVID-19) in Americans Aboard the Diamond Princess Cruise Ship.Clin Infect Dis. 2021 May 18;72(10):e448-e457. doi: 10.1093/cid/ciaa1180. Clin Infect Dis. 2021. PMID: 32785683 Free PMC article.
-
Navigating the risks of flying during COVID-19: a review for safe air travel.J Travel Med. 2020 Dec 23;27(8):taaa212. doi: 10.1093/jtm/taaa212. J Travel Med. 2020. PMID: 33184655 Free PMC article. Review.
-
Reopening International Borders without Quarantine: Contact Tracing Integrated Policy against COVID-19.Int J Environ Res Public Health. 2021 Jul 14;18(14):7494. doi: 10.3390/ijerph18147494. Int J Environ Res Public Health. 2021. PMID: 34299945 Free PMC article.
-
How coronavirus disease will change the face of travel medicine.Curr Opin Infect Dis. 2021 Oct 1;34(5):409-414. doi: 10.1097/QCO.0000000000000770. Curr Opin Infect Dis. 2021. PMID: 34267043 Review.
-
Estimating the effect of non-pharmaceutical interventions to mitigate COVID-19 spread in Saudi Arabia.BMC Med. 2022 Feb 7;20(1):51. doi: 10.1186/s12916-022-02232-4. BMC Med. 2022. PMID: 35125108 Free PMC article.
Cited by
-
International Travel for Organ Transplantation: A Survey of Professional Experiences and Attitudes Toward Data Collection and Reporting.Transplant Direct. 2024 Jun 13;10(7):e1655. doi: 10.1097/TXD.0000000000001655. eCollection 2024 Jul. Transplant Direct. 2024. PMID: 38881742 Free PMC article.
-
Emerging and re-emerging viral diseases, predisposing risk factors, and implications of international travel: a call for action for increasing vigilance and imposing restrictions under the current threats of recently emerging multiple Omicron subvariants.Int J Surg. 2023 Mar 1;109(3):589-591. doi: 10.1097/JS9.0000000000000176. Int J Surg. 2023. PMID: 37093096 Free PMC article. No abstract available.
-
Emotion Regulation and Mood during the COVID-19 Pandemic.J Clin Med. 2023 Apr 7;12(8):2758. doi: 10.3390/jcm12082758. J Clin Med. 2023. PMID: 37109095 Free PMC article.
-
Risk of COVID-19 transmission on long-haul flights: During the COVID-19 pandemic.PLoS One. 2024 Aug 16;19(8):e0309044. doi: 10.1371/journal.pone.0309044. eCollection 2024. PLoS One. 2024. PMID: 39150944 Free PMC article.
-
SARS-CoV-2 variant introduction following spring break travel and transmission mitigation strategies.PLoS One. 2024 May 9;19(5):e0301225. doi: 10.1371/journal.pone.0301225. eCollection 2024. PLoS One. 2024. PMID: 38722935 Free PMC article.
References
-
- World Tourism Organization. International tourism highlights, 2020 edition. UNWTO, Madrid. 2021. 10.18111/9789284422456.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous